1.Self-reported Non-celiac Gluten Sensitivity in the Korean Population: Demographic and Clinical Characteristics
Ra Ri CHA ; Jeong Hwan KIM ; Hoon Sup KOO ; Kee Wook JUNG ; Yang Won MIN ; Chang Hwan CHOI ; Han Seung RYU ; Yong Hwan KWON ; Dae Hyeon CHO ; Joong Goo KWON ; Kyung Sik PARK ; Hyun Jin KIM
Journal of Neurogastroenterology and Motility 2022;28(2):283-290
		                        		
		                        			 Background/Aims:
		                        			Non-celiac gluten sensitivity is characterized by intestinal and extra intestinal symptoms associated with the consumption of gluten-containing food. Since biomarkers for non-celiac gluten sensitivity are lacking, its prevalence is estimated based on self-reported symptoms. However, no data exist on self-reported non-celiac gluten sensitivity in the Korean population. Thus, we aim to investigate the prevalence of self-reported non-celiac gluten sensitivity in the Korean population and to determine its demographic and clinical characteristics. 
		                        		
		                        			Methods:
		                        			This study surveyed Korean participants aged 18-80 years who visited gastroenterology outpatient clinics at 9 tertiary hospitals in South Korea from January 2016 to February 2017. They were questioned regarding symptoms related to gluten ingestion: degree of discomfort (visual analog scale score), frequency, time of symptom onset, and duration. Abdominal discomfort caused by 11 differentkinds of gluten-containing Korean food items was investigated. 
		                        		
		                        			Results:
		                        			More non-celiac gluten sensitivity self-reporters were identified among those with irritable bowel syndrome (33.6%) than among controls (5.8%). Major gastrointestinal symptoms included bloating (75.0%), abdominal discomfort (71.3%), and belching (45.0%).Common extra-intestinal symptoms included fatigue (20.0%) and headache (13.7%). More than half of those who self-reported nonceliac gluten sensitivity (66.3%) developed symptoms within 1 hour of food ingestion, and symptoms were localized in the upper abdomen (37.5%) and entire abdomen (30.0%). 
		                        		
		                        			Conclusion
		                        			Our findings suggest that if there are gluten-related symptoms in irritable bowel syndrome, the possibility of accompanying non-celiacgluten sensitivity should be considered. 
		                        		
		                        		
		                        		
		                        	
2.A National Consensus Survey for Current Practicein Brain Tumor Management III: Brain Metastasis andPrimary Central Nervous System Lymphoma
Sung Kwon KIM ; Ji Eun PARK ; Kyung Hwan KIM ; Jin Mo CHO ; Jangsup MOON ; Wan-Soo YOON ; Se Hoon KIM ; Young Il KIM ; Young Zoon KIM ; Ho Sung KIM ; Yun-Sik DHO ; Jae-Sung PARK ; Hong In YOON ; Youngbeom SEO ; Kyoung Su SUNG ; Jin Ho SONG ; Chan Woo WEE ; Se-Hoon LEE ; Do Hoon LIM ; Jung Ho IM ; Jong Hee CHANG ; Myung-Hoon HAN ; Je Beom HONG ; Kihwan HWANG ; Chul-Kee PARK ; Youn Soo LEE ; Ho-Shin GWAK ;
Brain Tumor Research and Treatment 2020;8(1):20-28
		                        		
		                        			 Background:
		                        			: The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO)conducted the nationwide questionnaire survey for diverse queries facing to treat patients with braintumor. As part III of the survey, the aim of this study is to evaluate the national patterns of clinical practicefor patients with brain metastasis and primary central nervous system lymphoma (PCNSL). 
		                        		
		                        			Methods:
		                        			: A web-based survey was sent to all members of the KSNO by email. The survey included7 questions of brain metastasis and 5 questions of PCNSL, focused on the management strategiesin specific situations. All questions were developed by consensus of the Guideline WorkingGroup. 
		                        		
		                        			Results:
		                        			" In the survey about brain metastasis, respondents preferred surgical resection withadjuvant treatment for patients with a surgically accessible single brain metastatic lesion less than 3cm in size without extracranial systemic lesions. However, most respondents considered radiosurgeryfor surgically inaccessible lesions. As the preferred treatment of multiple brain metastases according tothe number of brain lesions, respondents tended to choose radiotherapy with increasing number of lesions.Radiosurgery was mostly chosen for the brain metastases of less than or equal to 4. In the surveyabout PCNSL, a half of respondents choose high-dose methotrexate-based polychemotherapy asthe first-line induction therapy for PCNSL. The consolidation and salvage therapy showed a little variationamong respondents. For PCNSL patients with cerebrospinal fluid dissemination, intrathecal chemotherapywas most preferred. 
		                        		
		                        			Conclusion
		                        			: The survey demonstrates the prevailing clinical practice patterns for patients withbrain metastasis and PCNSL among members of the KSNO. This information provides a point of referencefor establishing a practical guideline in the management of brain metastasis and PCNSL. 
		                        		
		                        		
		                        		
		                        	
3.A National Consensus Survey for Current Practicein Brain Tumor Management I: Antiepileptic Drug andSteroid Usage
Sung Kwon KIM ; Jangsup MOON ; Jin Mo CHO ; Kyung Hwan KIM ; Se Hoon KIM ; Young Il KIM ; Young Zoon KIM ; Ho Sung KIM ; Yun-Sik DHO ; Jae-Sung PARK ; Ji Eun PARK ; Youngbeom SEO ; Kyoung Su SUNG ; Jin Ho SONG ; Chan Woo WEE ; Wan-Soo YOON ; Hong In YOON ; Se-Hoon LEE ; Do Hoon LIM ; Jung Ho IM ; Jong Hee CHANG ; Myung-Hoon HAN ; Je Beom HONG ; Kihwan HWANG ; Chul-Kee PARK ; Youn Soo LEE ; Ho-Shin GWAK ;
Brain Tumor Research and Treatment 2020;8(1):1-10
		                        		
		                        			 Background:
		                        			: The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO)conducted a nationwide questionnaire survey for diverse queries faced in the treatment of brain tumors.As part I of the survey, the aim of this study is to evaluate national patterns of clinical practiceabout antiepileptic drug (AED) and steroid usage for management of brain tumors. 
		                        		
		                        			Methods:
		                        			: A web-based survey was sent to all members of the KSNO by email. The survey included9 questions of AED usage and 5 questions of steroid usage for brain tumor patients. All questionswere developed by consensus of the Guideline Working Group. 
		                        		
		                        			Results:
		                        			: The overall response rate was 12.8% (54/423). Regarding AED usage, the majority ofrespondents (95.2%) routinely prescribed prophylactic AEDs for patients with seizure at the peri/postoperativeperiod. However, as many as 72.8% of respondents prescribed AED routinely for seizure-naïvepatients, and others prescribed AED as the case may be. The duration of AED prophylaxis showedwide variance according to the epilepsy status and the location of tumor. Levetiracetam (82.9%) wasthe most preferred AED for epilepsy prophylaxis. Regarding steroid usage, 90.5% of respondents usesteroids in perioperative period, including 34.2% of them as a routine manner. Presence of peritumoraledema (90.9%) was considered as the most important factor determining steroid usage followed bydegree of clinical symptoms (60.6%). More than half of respondents (51.2%) replied to discontinue thesteroids within a week after surgery if there are no specific medical conditions, while 7.3% preferredslow tapering up to a month after surgery. 
		                        		
		                        			Conclusion
		                        			: The survey demonstrated the prevailing practice patterns on AED and steroid usagein neuro-oncologic field among members of the KSNO. This information provides a point of referencefor establishing a practical guideline in the management of brain tumor patients. 
		                        		
		                        		
		                        		
		                        	
4.A National Consensus Survey for Current Practicein Brain Tumor Management II:Diffuse Midline Glioma and Meningioma
Sung Kwon KIM ; Hong In YOON ; Wan-Soo YOON ; Jin Mo CHO ; Jangsup MOON ; Kyung Hwan KIM ; Se Hoon KIM ; Young Il KIM ; Young Zoon KIM ; Ho Sung KIM ; Yun-Sik DHO ; Jae-Sung PARK ; Ji Eun PARK ; Youngbeom SEO ; Kyoung Su SUNG ; Jin Ho SONG ; Chan Woo WEE ; Se-Hoon LEE ; Do Hoon LIM ; Jung Ho IM ; Jong Hee CHANG ; Myung-Hoon HAN ; Je Beom HONG ; Kihwan HWANG ; Chul-Kee PARK ; Youn Soo LEE ; Ho-Shin GWAK ;
Brain Tumor Research and Treatment 2020;8(1):11-19
		                        		
		                        			 Background:
		                        			: The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO)conducted a nationwide questionnaire survey for diverse queries faced in the treatment of brain tumors.As part II of the survey, the aim of this study is to evaluate the national patterns of clinical practicefor patients with diffuse midline glioma and meningioma. 
		                        		
		                        			Methods:
		                        			: A web-based survey was sent to all members of the KSNO by email. The survey included4 questions of diffuse midline glioma and 6 questions of meningioma (including 2 case scenarios).All questions were developed by consensus of the Guideline Working Group. 
		                        		
		                        			Results:
		                        			: In the survey about diffuse midline glioma, 76% respondents performed histologicconfirmation to identify H3K27M mutation on immunohistochemical staining or sequencing methods.For treatment of diffuse midline glioma, respondents preferred concurrent chemoradiotherapy withtemozolomide (TMZ) and adjuvant TMZ (63.8%) than radiotherapy alone (34.0%). In the surveyabout meningioma, respondents prefer wait-and-see policy for the asymptomatic small meningiomawithout peritumoral edema. However, a greater number of respondents had chosen surgical resectionas the first choice for all large size meningiomas without exception, and small size meningiomaswith either peritumoral edema or eloquent location. There was no single opinion with major consensuson long-term follow-up plans for asymptomatic meningioma with observation policy. As many as68.1% of respondents answered that they would not add any adjuvant therapies for World Health Organizationgrade II meningiomas if the tumor was totally resected including dura. 
		                        		
		                        			Conclusion
		                        			: The survey demonstrates the prevailing clinical practice patterns for patients with diffusemidline glioma and meningioma among members of the KSNO. This information provides a pointof reference for establishing a practical guideline in the management of diffuse midline glioma andmeningioma. 
		                        		
		                        		
		                        		
		                        	
5.Erratum to: Causal Inference Network of Genes Related with Bone Metastasis of Breast Cancer and Osteoblasts Using Causal Bayesian Networks
Sung Bae PARK ; Chun Kee CHUNG ; Efrain GONZALEZ ; Changwon YOO
Journal of Bone Metabolism 2019;26(1):61-61
		                        		
		                        			
		                        			The Acknowledgement was published incorrectly.
		                        		
		                        		
		                        		
		                        	
6.Lamina Cribrosa Changes after Laser In Situ Keratomileusis in Myopic Eyes.
Soomin LEE ; Da Ye Diana CHOI ; Dong Hui LIM ; Tae Young CHUNG ; Jong Chul HAN ; Changwon KEE
Korean Journal of Ophthalmology 2018;32(2):95-102
		                        		
		                        			
		                        			PURPOSE: To determine deep optic nerve head structure changes after transient intraocular pressure elevation during laser in situ keratomileusis (LASIK) for myopia. METHODS: Enhanced depth imaging-optical coherence tomography was performed in each myopic eye that underwent LASIK surgery. Enhanced depth imaging-optical coherence tomography images were created at postoperative 1 day, 1 week, 2 weeks, and 1 month. Lamina cribrosa (LC) thickness, LC depth and prelaminar thickness at the superior, middle and inferior portions of the optic nerve head were measured by two investigators. RESULTS: Forty eyes in 40 patients were included in the present study. During follow-up, there were no significant differences in prelaminar thickness or LC depth. The LC demonstrated increased thickness at postoperative 1 day at all three locations (superior, middle, and inferior) (p < 0.001, p < 0.001, p < 0.001, respectively). However, no significant changes were observed at postoperative 1 week, 2 weeks, and 1 month. CONCLUSIONS: The LC thickness could increase at 1 day after LASIK surgery. However, the thickness will gradually return to baseline morphology. Temporary intraocular pressure increase during LASIK does not appear to induce irreversible LC thickness changes.
		                        		
		                        		
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Intraocular Pressure
		                        			;
		                        		
		                        			Keratomileusis, Laser In Situ*
		                        			;
		                        		
		                        			Myopia
		                        			;
		                        		
		                        			Optic Disk
		                        			;
		                        		
		                        			Research Personnel
		                        			
		                        		
		                        	
7.PITX2-related Axenfeld-Rieger Syndrome with a Novel Pathogenic Variant (c.475_476delCT).
Jong Eun PARK ; Eun Jung LEE ; Chang Seok KI ; Changwon KEE
Annals of Laboratory Medicine 2018;38(3):283-286
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        	
8.Causal Inference Network of Genes Related with Bone Metastasis of Breast Cancer and Osteoblasts Using Causal Bayesian Networks.
Sung Bae PARK ; Chun Kee CHUNG ; Efrain GONZALEZ ; Changwon YOO
Journal of Bone Metabolism 2018;25(4):251-266
		                        		
		                        			
		                        			BACKGROUND: The causal networks among genes that are commonly expressed in osteoblasts and during bone metastasis (BM) of breast cancer (BC) are not well understood. Here, we developed a machine learning method to obtain a plausible causal network of genes that are commonly expressed during BM and in osteoblasts in BC. METHODS: We selected BC genes that are commonly expressed during BM and in osteoblasts from the Gene Expression Omnibus database. Bayesian Network Inference with Java Objects (Banjo) was used to obtain the Bayesian network. Genes registered as BC related genes were included as candidate genes in the implementation of Banjo. Next, we obtained the Bayesian structure and assessed the prediction rate for BM, conditional independence among nodes, and causality among nodes. Furthermore, we reported the maximum relative risks (RRs) of combined gene expression of the genes in the model. RESULTS: We mechanistically identified 33 significantly related and plausibly involved genes in the development of BC BM. Further model evaluations showed that 16 genes were enough for a model to be statistically significant in terms of maximum likelihood of the causal Bayesian networks (CBNs) and for correct prediction of BM of BC. Maximum RRs of combined gene expression patterns showed that the expression levels of UBIAD1, HEBP1, BTNL8, TSPO, PSAT1, and ZFP36L2 significantly affected development of BM from BC. CONCLUSIONS: The CBN structure can be used as a reasonable inference network for accurately predicting BM in BC.
		                        		
		                        		
		                        		
		                        			Bayes Theorem
		                        			;
		                        		
		                        			Breast Neoplasms*
		                        			;
		                        		
		                        			Breast*
		                        			;
		                        		
		                        			Gene Expression
		                        			;
		                        		
		                        			Indonesia
		                        			;
		                        		
		                        			Machine Learning
		                        			;
		                        		
		                        			Methods
		                        			;
		                        		
		                        			Neoplasm Metastasis*
		                        			;
		                        		
		                        			Osteoblasts*
		                        			
		                        		
		                        	
9.Clinical Outcomes of Differentiated Thyroid Cancer Patients with Local Recurrence or Distant Metastasis Detected in Old Age.
Ji Min HAN ; Ji Cheol BAE ; Hye In KIM ; Sam KWON ; Min Ji JEON ; Won Gu KIM ; Tae Yong KIM ; Young Kee SHONG ; Won Bae KIM
Endocrinology and Metabolism 2018;33(4):459-465
		                        		
		                        			
		                        			BACKGROUND: Differentiated thyroid carcinoma (DTC) shows a very good prognosis, but older patients have a higher recurrence rate and those show poor prognosis than younger patients. The aim of this study was to determine the clinical outcomes of thyroid cancer patients who experienced recurrence in old age according to the treatment strategy used. METHODS: This retrospective observational cohort study was conducted at Asan Medical Center, Seoul, Korea. Among DTC patients with no evidence of disease after initial treatment, we enrolled 86 patients who experienced recurrence at an age >65 years from 1994 to 2012. Sixty-nine patients had local recurrence and 17 patients showed distant metastasis. RESULTS: The mean age of patients at recurrence was 72 years. Patients were followed up for a median of 4.1 years after recurrence. Sixty-three of the 69 patients with local recurrence received additional treatment, while the other six received conservative care. The cancer-specific mortality rate was 15.5% in the local recurrence group. Airway problems were the main cause of death in patients who did not receive further treatment for local recurrence. Among the 17 patients with distant metastasis, 10 underwent specific treatment for metastasis and seven received only supportive management. Seven of those 17 patients died, and the cancer-specific mortality rate was 35% in the distant metastasis group. CONCLUSION: The overall cancer-specific mortality rate was 20% in DTC patients in whom recurrence was first detected at an age >65 years. Mortality due to uncontrolled local disease occurred frequently in patients who did not receive definitive management for recurrence.
		                        		
		                        		
		                        		
		                        			Cause of Death
		                        			;
		                        		
		                        			Chungcheongnam-do
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Mortality
		                        			;
		                        		
		                        			Neoplasm Metastasis*
		                        			;
		                        		
		                        			Neoplasm Recurrence, Local
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Recurrence*
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Seoul
		                        			;
		                        		
		                        			Thyroid Gland*
		                        			;
		                        		
		                        			Thyroid Neoplasms*
		                        			
		                        		
		                        	
10.Peripapillary Retinal Nerve Fiber Layer Thicknesses Did Not Change in Long-term Hydroxychloroquine Users.
Eun Jung LEE ; Sang Jin KIM ; Jong Chul HAN ; Doo Ri EO ; Min Gyu LEE ; Don Il HAM ; Se Woong KANG ; Changwon KEE ; Jaejoon LEE ; Hoon Suk CHA ; Eun Mi KOH
Korean Journal of Ophthalmology 2018;32(6):459-469
		                        		
		                        			
		                        			PURPOSE: To evaluate changes in the peripapillary retinal nerve fiber layer (RNFL) thicknesses using spectral-domain optical coherence tomography (SD-OCT) in hydroxychloroquine (HCQ) users. METHODS: The medical records of HCQ users were retrospectively reviewed. In these HCQ users, an automated perimetry, fundus autofluorescence photography, and SD-OCT with peripapillary RNFL thickness measurements were performed. The peripapillary RNFL thicknesses were compared between the HCQ users and the control groups. The relationships between the RNFL thicknesses and the duration or cumulative dosage of HCQ use were analyzed. RESULTS: This study included 77 HCQ users and 20 normal controls. The mean duration of HCQ usage was 63.6 ± 38.4 months, and the cumulative dose of HCQ was 528.1 ± 3.44 g. Six patients developed HCQ retinopathy. Global and six sectoral RNFL thicknesses of the HCQ users did not significantly decrease compared to those of the normal controls. No significant correlation was found between the RNFL thickness and the duration of use or cumulative dose. The eyes of those with HCQ retinopathy had temporal peripapillary RNFL thicknesses significantly greater than that of normal controls. CONCLUSIONS: The peripapillary RNFL thicknesses did not change in the HCQ users and did not correlate with the duration of HCQ use or cumulative doses of HCQ. RNFL thickness is not a useful biomarker for the early detection of HCQ retinal toxicity.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hydroxychloroquine*
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Nerve Fibers*
		                        			;
		                        		
		                        			Photography
		                        			;
		                        		
		                        			Retinaldehyde*
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Tomography, Optical Coherence
		                        			;
		                        		
		                        			Visual Field Tests
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail